![]() |
Volumn 23, Issue 25, 2014, Pages 6826-6837
|
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
AZACITIDINE;
CDKN2D PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE INHIBITOR 2D;
DECITABINE;
MYCN PROTEIN, HUMAN;
NUCLEAR PROTEIN;
ONCOPROTEIN;
RETINOIC ACID;
ADOLESCENT;
ADULT;
ANALOGS AND DERIVATIVES;
CANCER STAGING;
CELL DIFFERENTIATION;
CHILD;
DNA METHYLATION;
DRUG EFFECTS;
FEMALE;
GENE EXPRESSION REGULATION;
GENETIC EPIGENESIS;
GENETICS;
HUMAN;
INFANT;
MALE;
METABOLISM;
MORTALITY;
NERVE CELL;
NERVOUS SYSTEM TUMOR;
NEUROBLASTOMA;
NEWBORN;
PATHOLOGY;
PRESCHOOL CHILD;
SIGNAL TRANSDUCTION;
SURVIVAL;
TUMOR CELL LINE;
ADOLESCENT;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
AZACITIDINE;
CELL DIFFERENTIATION;
CELL LINE, TUMOR;
CHILD;
CHILD, PRESCHOOL;
CYCLIN-DEPENDENT KINASE INHIBITOR P19;
DNA METHYLATION;
EPIGENESIS, GENETIC;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
NEOPLASM STAGING;
NERVOUS SYSTEM NEOPLASMS;
NEUROBLASTOMA;
NEURONS;
NUCLEAR PROTEINS;
ONCOGENE PROTEINS;
SIGNAL TRANSDUCTION;
SURVIVAL ANALYSIS;
TRETINOIN;
|
EID: 84938718430
PISSN: None
EISSN: 14602083
Source Type: Journal
DOI: 10.1093/hmg/ddu406 Document Type: Article |
Times cited : (21)
|
References (0)
|